China Grand Pharmaceutical and Healthcare Holdings Ltd

Detailed Description

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers pharmaceutical preparations, including cerebro-cardiovascular emergency medicines; respiratory, ophthalmic, anti-infection, and ENT medicines; oncology medicines; and rare disease medicines. It also provides medical devices, such as dilatation catheters; intravascular ultrasound optical coherence tomography systems; intracardiac ultrasound systems; and ophthalmology related devices. In addition, the company offers biotechnology and health products, such as Taurine, amino acid products, steroid products, and bio-pesticides and agricultural antibiotics; and specialized pharmaceutical raw materials and other products, including metronidazole, chloramphenicol, epinephrine, dimethyl sulfate, nitromethane, etc. Further, the company offers agrochemicals, ophthalmic gel and eye drops, steroid hormones active pharmaceutical ingredients and related intermediates, bio-pesticides and additives, disposal surgical products, and Chinese medicine and health food products; and engages in the treatment of sewage. It operates in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. It has a strategic cooperation eTheRNA Immunotherapies NV, Cardionovum GmbH, Conavi Medical Inc, and Glenmark Specialty S.A.; and product licensing agreement with Cloudbreak Pharmaceutical Inc. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited and changed its name to Grand Pharmaceutical Group Limited in November 2021. Grand Pharmaceutical Group Limited was incorporated in 1995 and is based in Central, Hong Kong.